Safety and Efficacy Of Eltrombopag At Escalated Doses Up To 150mg In Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Not Responsive To 75 Mg
| Autor: | McGuinn, Catherine E., Imahiyerobo, Allison *, Thompson, Micha *, Haq, Naznin *, Tchatchouang, Claudia *, Bussel, James B |
|---|---|
| Zdroj: | In Blood 15 November 2013 122(21):3559-3559 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|